TENDER AND SUPPORT AGREEMENTTender and Support Agreement • January 12th, 2015 • Foundation Medicine, Inc. • Services-medical laboratories • Delaware
TENDER AND SUPPORT AGREEMENT (this “Agreement”) dated as of January 11, 2015 by and among Roche Holdings, Inc., a Delaware corporation (the “Investor”), and the entity listed on Schedule A hereto (the “VC Shareholder”).
FOUNDATION MEDICINE, INC. AMENDMENT TO SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • January 12th, 2015 • Foundation Medicine, Inc. • Services-medical laboratories • Delaware
This Amendment to Second Amended and Restated Investors’ Rights Agreement (this “Amendment”), is executed as of January 11, 2015, by the undersigned Investors (as defined herein) and Foundation Medicine, Inc., a Delaware corporation (the “Company”). Reference is hereby made to that certain Second Amended and Restated Investors’ Rights Agreement, dated as of June 20, 2013 (the “Existing Rights Agreement”), by and among the Company and the investors listed on Schedule A thereto (each, an “Investor”). Capitalized terms used herein that are not otherwise defined shall have the meaning ascribed thereto in the Existing Rights Agreement.
TAX SHARING AGREEMENTTax Sharing Agreement • January 12th, 2015 • Foundation Medicine, Inc. • Services-medical laboratories • Delaware
TAX SHARING AGREEMENT (the “Agreement”) dated as of January 11, 2015, and effective as of the Effective Date (as defined in Section 15.01 of this Agreement), by and between Roche Holdings, Inc., a Delaware corporation, hereinafter referred to as “RHI”, and Foundation Medicine, Inc., a Delaware corporation, hereinafter referred to as “HERMES”.
